This behavior appears to be linked to the regulation of epithelial–mesenchymal transition (EMT) mediated by podoplanin [47,48], which confers tumor cells with a pro-migratory phenotype and provides an oncogenic advantage through the acquisition of the cancer hallmark “activating invasion and metastasis” [8,9]. The gene discussed is PDPN; the disease is cancer.